About Us
The vision of the CTTB is to learn from the accumulated real-world data of patients treated with biologic therapies at the MUHC. Participants are consented to share their clinical data and biological samples as per REB-approved guidelines.
Samples of prevalent users of biologics are studied to understand treatment effectiveness and any adverse events while correlating biological samples with clinical outcomes.
We aim to create a registry and biobank from participants to facilitate cutting-edge research on disease mechanisms and to identify biomarkers that could aid in new treatment options.
CTTB biobank at the research institute of McGill University Health Centre (RI-MUHC) is working to collect and learn from the real-world data of patients treated with biologic therapies. The study participants are recruited and consented to share their clinical data and biological specimens for current and future research initiatives. The entire process is thoroughly reviewed by the Research Ethics Board (REB) on the validity of the study design, safety, and confidentiality of clinical and patient information.